{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:22:52Z","timestamp":1794619372197,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50941-0","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:15:51Z","timestamp":1780438551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World Study"],"prefix":"10.1038","volume":"16","author":[{"given":"Alessandro","family":"Conforti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alarico","family":"Ariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Cataldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Becciolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Marchesoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Addimanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Celletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Andracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marino","family":"Paroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Del Medico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palma","family":"Scolieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Ianniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Lumetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Giampietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Mazzanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Visalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosetta","family":"Vitetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Priora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Ravagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Raffeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Biagio","family":"Molica Colella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Larosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Girelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ometto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Nucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Serale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Caccavale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mansueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Smerilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Ditto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bixio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Focherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Mascella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Di Penta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fiorenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Murgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Rovera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Angrisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuditta","family":"Adorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Santilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylenia Dal","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Molica Colella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Plate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerolamo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Marchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Santoboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Camellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cipollone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fusaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Arrigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Lucchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilia","family":"Giuggioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Reta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lo Gullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"3","key":"50941_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-013-0316-4","volume":"15","author":"L Eder","year":"2013","unstructured":"Eder, L. & Gladman, D. D. Psoriatic arthritis: Phenotypic variance and nosology. Curr. Rheumatol. Rep. 15(3), 316. https:\/\/doi.org\/10.1007\/s11926-013-0316-4 (2013).","journal-title":"Curr. Rheumatol. Rep."},{"issue":"12","key":"50941_CR2","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.3390\/jcm12123892","volume":"12","author":"A Lo Gullo","year":"2023","unstructured":"Lo Gullo, A. et al. Therapeutic effects of apremilast on enthesitis and dactylitis in real clinical setting: An Italian Multicenter Study. J Clin Med. 12(12), 3892 (2023).","journal-title":"J Clin Med."},{"issue":"3","key":"50941_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkae074","volume":"8","author":"AL Ribeiro","year":"2024","unstructured":"Ribeiro, A. L. et al. Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): A GRAPPA perspective from an international survey of healthcare professionals. Rheumatol. Adv. Pract. 8(3), rkae074. https:\/\/doi.org\/10.1093\/rap\/rkae074 (2024).","journal-title":"Rheumatol. Adv. Pract."},{"issue":"2","key":"50941_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004080","volume":"10","author":"GH Koc","year":"2024","unstructured":"Koc, G. H. et al. Determinants of radiographic progression in early psoriatic arthritis: Insights from a real-world cohort. RMD Open 10(2), e004080. https:\/\/doi.org\/10.1136\/rmdopen-2024-004080 (2024).","journal-title":"RMD Open"},{"issue":"6","key":"50941_CR5","doi-asserted-by":"publisher","first-page":"700.1","DOI":"10.1136\/annrheumdis-2020-217159","volume":"79","author":"L Gossec","year":"2020","unstructured":"Gossec, L. et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 Update. Ann. Rheum. Dis. 79(6), 700.1-712. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217159 (2020).","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"50941_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3899\/jrheum.151042","volume":"43","author":"F Iannone","year":"2016","unstructured":"Iannone, F. et al. Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings. J. Rheumatol. 43(5), 911\u2013917. https:\/\/doi.org\/10.3899\/jrheum.151042 (2016).","journal-title":"J. Rheumatol."},{"key":"50941_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates, L. C., Fransen, J. & Helliwell, P. S. Defining minimal disease activity in psoriatic arthritis: A proposed objective target for treatment. Ann. Rheum. Dis. 69, 48\u201353. https:\/\/doi.org\/10.1136\/ard.2008.102053 (2010).","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"50941_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.46497\/ArchRheumatol.2024.10710","volume":"39","author":"C Lopez-Medina","year":"2024","unstructured":"Lopez-Medina, C., Kalyoncu, U. & Gossec, L. Unmet needs in psoriatic arthritis, a narrative review. Arch. Rheumatol. 39(2), 159\u2013171. https:\/\/doi.org\/10.46497\/ArchRheumatol.2024.10710 (2024).","journal-title":"Arch. Rheumatol."},{"issue":"4","key":"50941_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaf094","volume":"9","author":"A Becciolini","year":"2025","unstructured":"Becciolini, A. et al. Guselkumab effectiveness in real-world settings: Observations from an Italian multicentre study. Rheumatol. Adv. Pract. 9(4), rkaf094 (2025).","journal-title":"Rheumatol. Adv. Pract."},{"key":"50941_CR10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0140-6736(20)30263-4","volume":"395","author":"PJ Mease","year":"2020","unstructured":"Mease, P. J. et al. Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): A double-blind, randomised, place-bocontrolled phase 3 trial. Lancet 395, 1126\u20131136 (2020).","journal-title":"Lancet"},{"key":"50941_CR11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0140-6736(20)30265-8","volume":"395","author":"A Deodhar","year":"2020","unstructured":"Deodhar, A. et al. Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNF\u03b1 inhibitor treatment (DISCOVER-1): A double-blind, randomised, placebo-controlled phase 3 trial. Lancet 395, 1115\u20131125 (2020).","journal-title":"Lancet"},{"key":"50941_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/annrheumdis-2021-220991","volume":"81","author":"LC Coates","year":"2022","unstructured":"Coates, L. C. et al. Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: Results through one year of a phase IIIb, randomised, controlled study (COSMOS). Ann. Rheum. Dis. 81, 359\u2013369 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"50941_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/art.42010","volume":"74","author":"IB McInnes","year":"2022","unstructured":"McInnes, I. B. et al. Long-term efficacy and safety of guselkumab, a monoclonal antibody specific to the p19 subunit of interleukin-23, through two years: results from a phase III, randomized, double-blind, placebo-controlled study conducted in biologic-na\u00efve patients with active psoriatic arthritis. Arthritis Rheumatol. 74, 475\u2013485 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"50941_CR14","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/rheumatology\/keab509","volume":"61","author":"I Pantano","year":"2022","unstructured":"Pantano, I. et al. Real-life efficacy of guselkumab in patients with early psoriatic arthritis. Rheumatology 61, 1217\u20131221 (2022).","journal-title":"Rheumatology"},{"key":"50941_CR15","first-page":"1122","volume":"63","author":"P Ruscitti","year":"2024","unstructured":"Ruscitti, P. et al. Short-term effectiveness of guselkumab in psoriatic arthritis patients and suggestive features of axial involvement: Results from a real-life multicentre cohort. Rheumatology 63, 1122\u20131130 (2024).","journal-title":"Rheumatology"},{"key":"50941_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s40744-024-00649-2","volume":"11","author":"P Ruscitti","year":"2024","unstructured":"Ruscitti, P. et al. The evaluation of effectiveness and safety of guselkumab in patients with psoriatic arthritis in a prospective multicentre \u201cReal-Life\u201d cohort study. Rheumatol. Ther. 11, 539\u2013551 (2024).","journal-title":"Rheumatol. Ther."},{"key":"50941_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/acr2.11657","volume":"6","author":"PJ Mease","year":"2024","unstructured":"Mease, P. J. et al. Improvements in patient-reported outcomes through six months of guselkumab treatment in patients with active psoriatic arthritis: Real-world data from the CorEvitas Psoriatic Arthritis\/Spondyloarthritis Registry. ACR Open Rheumatol. 6, 304\u2013311 (2024).","journal-title":"ACR Open Rheumatol."},{"key":"50941_CR18","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s40744-023-00582-w","volume":"10","author":"PJ Mease","year":"2023","unstructured":"Mease, P. J. et al. Six-month persistence and multi-domain effectiveness of guselkumab in adults with psoriatic arthritis: Real-world data from the CorEvitas Psoriatic Arthritis\/Spondyloarthritis Registry. Rheumatol. Ther. 10, 1479\u20131501 (2023).","journal-title":"Rheumatol. Ther."},{"issue":"12","key":"50941_CR19","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.3390\/jcm14124111","volume":"14","author":"F Atzeni","year":"2025","unstructured":"Atzeni, F. et al. Italian multicenter real-world study on the twelve-month effectiveness, safety, and retention rate of guselkumab in psoriatic arthritis patients. J Clin Med. 14(12), 4111 (2025).","journal-title":"J Clin Med."},{"issue":"11","key":"50941_CR20","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1093\/rheumatology\/keab285","volume":"60","author":"D McGonagle","year":"2021","unstructured":"McGonagle, D. et al. Resolution of enthesitis by Guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies. Rheumatology 60(11), 5337\u20135350 (2021).","journal-title":"Rheumatology"},{"key":"50941_CR21","first-page":"152134","volume-title":"Seminars in Arthritis and Rheumatism","author":"EE Schneeberger","year":"2023","unstructured":"Schneeberger, E. E. et al. Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies. In Seminars in Arthritis and Rheumatism Vol. 58 152134 (WB Saunders, 2023)."},{"issue":"7","key":"50941_CR22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock, J. P. et al. IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells. Nat. Med. 18(7), 1069\u20131076. https:\/\/doi.org\/10.1038\/nm.2817 (2012).","journal-title":"Nat. Med."},{"key":"50941_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637829","volume":"12","author":"C Schinocca","year":"2021","unstructured":"Schinocca, C. et al. Role of the IL-23\/IL-17 pathway in rheumatic diseases: An overview. Front. Immunol. 12, 637829. https:\/\/doi.org\/10.3389\/fimmu.2021.637829 (2021).","journal-title":"Front. Immunol."},{"issue":"3","key":"50941_CR24","first-page":"487","volume":"11","author":"JA Walsh","year":"2024","unstructured":"Walsh, J. A. et al. Comparison of real-world on-label treatment persistence in patients with psoriatic arthritis receiving Guselkumab versus subcutaneous tumor necrosis factor inhibitors. Drugs 11(3), 487\u2013499 (2024).","journal-title":"Drugs"},{"issue":"5","key":"50941_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/annrheumdis-2020-218186","volume":"80","author":"A Nerviani","year":"2021","unstructured":"Nerviani, A. et al. IL-23 skin and joint profiling in psoriatic arthritis: Novel perspectives in un-derstanding clinical responses to IL-23 inhibitors. Ann. Rheum. Dis. 80(5), 591\u2013597 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"50941_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/art.43286","author":"LE Durham","year":"2025","unstructured":"Durham, L. E. et al. Linking skin and joint inflammation in psoriatic arthritis through shared CD8+ T cell clones. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.43286 (2025).","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"50941_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18513-6","volume":"11","author":"F Penkava","year":"2020","unstructured":"Penkava, F. et al. Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis. Nat. Commun. 11(1), 4767. https:\/\/doi.org\/10.1038\/s41467-020-18513-6 (2020).","journal-title":"Nat. Commun."},{"issue":"Suppl 1(Suppl 1","key":"50941_CR28","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1002\/msc.1694","volume":"20","author":"GE Fragoulis","year":"2022","unstructured":"Fragoulis, G. E. & Siebert, S. The role of IL-23 and the use of IL-23 inhibitors in psoriatic arthritis. Musculoskelet. Care 20(Suppl 1(Suppl 1)), S12\u2013S21. https:\/\/doi.org\/10.1002\/msc.1694 (2022).","journal-title":"Musculoskelet. Care"},{"issue":"12","key":"50941_CR29","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.3390\/jcm14124111","volume":"14","author":"F Atzeni","year":"2025","unstructured":"Atzeni, F. et al. Italian multicenter real-world study on the twelve-month effectiveness, safety, and retention rate of guselkumab in psoriatic arthritis patients. J. Clin. Med. 14(12), 4111. https:\/\/doi.org\/10.3390\/jcm14124111 (2025).","journal-title":"J. Clin. Med."},{"issue":"2","key":"50941_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/ard.2009.111856","volume":"69","author":"F Van den Bosch","year":"2010","unstructured":"Van den Bosch, F. et al. Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann. Rheum. Dis. 69(2), 394\u2013399 (2010).","journal-title":"Ann. Rheum. Dis."},{"issue":"30","key":"50941_CR31","first-page":"S75","volume":"1","author":"DC Sandoval","year":"2023","unstructured":"Sandoval, D. C. & Fern\u00e1ndez-\u00c1vila, D. G. Assessment tools in psoriatic arthritis: A review. Rev. Colomb. Reumatol. 1(30), S75-86 (2023).","journal-title":"Rev. Colomb. Reumatol."},{"issue":"3","key":"50941_CR32","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10067-023-06859-3","volume":"43","author":"S He","year":"2024","unstructured":"He, S. et al. Sex-specific differences in patients with psoriatic arthritis: A nationwide study from the Chinese Registry of Psoriatic Arthritis (CREPAR IV). Clin. Rheumatol. 43(3), 1063\u20131071 (2024).","journal-title":"Clin. Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50941-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50941-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50941-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:06:12Z","timestamp":1786579572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50941-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50941"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50941-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25243"}}